propranolol has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gean, PW; Huang, CC; Lin, JH; Tsai, JJ | 1 |
| Andreasen, M; Lambert, JD | 1 |
| Davidoff, RA; Hackman, JC; Holohean, AM; Shope, SB | 1 |
| Crepel, F; Hirsch, JC; Law-Tho, D | 1 |
| Grünschlag, CR; Haas, HL; Stevens, DR | 1 |
| Ameri, A; Seitz, U | 1 |
| Piguet, P; Schlichter, R; Stoeckel, ME | 1 |
| Aroniadou-Anderjaska, V; Braga, MF; Hough, CJ; Li, H; Manion, ST | 1 |
| Chen, PS; Gean, PW; Lin, HC; Mao, SC; Tseng, YC | 1 |
9 other study(ies) available for propranolol and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Sustained enhancement of NMDA receptor-mediated synaptic potential by isoproterenol in rat amygdalar slices.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Animals; Bicuculline; Evoked Potentials; In Vitro Techniques; Isoproterenol; Membrane Potentials; Propranolol; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Synapses; Time Factors | 1992 |
Noradrenaline receptors participate in the regulation of GABAergic inhibition in area CA1 of the rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Atenolol; Bicuculline; Clonidine; Dose-Response Relationship, Drug; Evoked Potentials; Female; gamma-Aminobutyric Acid; Hippocampus; Male; Membrane Potentials; Norepinephrine; Propranolol; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, GABA-A; Synapses | 1991 |
Activation of alpha-adrenoceptors indirectly facilitates sodium pumping in frog motoneurons.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids; Animals; Clonidine; Motor Neurons; N-Methylaspartate; Norepinephrine; Prazosin; Propranolol; Quinoxalines; Rana pipiens; Sodium-Potassium-Exchanging ATPase; Spinal Cord; Tetrodotoxin | 1993 |
Noradrenaline decreases transmission of NMDA- and non-NMDA-receptor mediated monosynaptic EPSPs in rat prefrontal neurons in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adrenergic Antagonists; Afferent Pathways; Animals; Clonidine; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Antagonists; In Vitro Techniques; Isoproterenol; Membrane Potentials; Methoxamine; Neurons; Norepinephrine; Phentolamine; Phenylephrine; Prazosin; Prefrontal Cortex; Propranolol; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission | 1993 |
5-HT inhibits lateral entorhinal cortical neurons of the rat in vitro by activation of potassium channel-coupled 5-HT1A receptors.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; 8-Hydroxy-2-(di-n-propylamino)tetralin; Anesthetics, Local; Animals; Electrophysiology; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Lidocaine; Lysine; Male; Neural Inhibition; Neurons; Perforant Pathway; Potassium; Potassium Channels; Propranolol; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists; Sympatholytics | 1997 |
Effects of mesaconitine on [3H]noradrenaline uptake and neuronal excitability in rat hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Aconitine; Action Potentials; Adrenergic beta-Antagonists; Animals; Electrophysiology; Excitatory Amino Acid Antagonists; Hippocampus; Male; Neurons; Norepinephrine; Organ Culture Techniques; Propranolol; Rats; Rats, Wistar; Tritium | 1998 |
Synaptically released 5-HT modulates the activity of tonically discharging neuronal populations in the rostral ventral medulla (RVM).
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bicuculline; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fenfluramine; GABA Antagonists; Glycine Agents; Ketanserin; Medulla Oblongata; Neural Inhibition; Neurons; Organ Culture Techniques; Piperazines; Prazosin; Propranolol; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Strychnine; Synaptic Transmission | 2000 |
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aging; Amygdala; Anesthetics, Local; Animals; Animals, Newborn; Bicuculline; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Estrenes; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Morpholines; Neural Inhibition; Neurons; Norepinephrine; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Restraint, Physical; Stress, Physiological; Tetrahydronaphthalenes; Tetrodotoxin; Time Factors | 2004 |
GABAA receptor endocytosis in the basolateral amygdala is critical to the reinstatement of fear memory measured by fear-potentiated startle.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic beta-Agonists; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Biotinylation; Conditioning, Classical; Dynamins; Endocytosis; Excitatory Amino Acid Antagonists; Extinction, Psychological; Fear; Immunoprecipitation; Isoproterenol; Male; Maze Learning; Memory; Patch-Clamp Techniques; Propranolol; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Recombinant Fusion Proteins; Reward; Synaptic Transmission; tat Gene Products, Human Immunodeficiency Virus; Valine | 2011 |